Search Results - "Avendano Solá, C."

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    On heterogeneity of treatment effects and clinical freedom by Sacristán, J A, Avendaño-Solá, C

    “…Three decades ago, John R Hampton announced the death of clinical freedom. Since then, evidence-based medicine has been the predominant paradigm in clinical…”
    Get more information
    Journal Article
  2. 2
  3. 3
  4. 4

    Sentia: A Spanish Systematic Online Monitoring Registry for Children And Adolescents Treated With Antipsychotics: Results from A 2-Year, Naturalistic Follow-Up Study by Centeno Soto, G, Ruiz-Antorán, B, Palanca Maresca, I, Forti-Buratti, A, Avendaño-Solá, C

    Published in Clinical therapeutics (01-08-2015)
    “…SENTIA (SafEty of NeurolepTics in Infancy and Adolescence; (https://sentia.es), is an online Spanish registry created to track antipsychotic adverse effects in…”
    Get full text
    Journal Article
  5. 5

    Conversion from Tacrolimus Twice-Daily to Tacrolimus Once-Daily In Stable Cystic Fibrosis Lung Transplant Recipients: Comparative Pharmacokinetics by Centeno Soto, G, Ruiz-Antorán, B, Sancho López, A, Payares, C, Fernández, F.J, Ussetti, P, Avendaño-Solá, C

    Published in Clinical therapeutics (01-08-2015)
    “…Objectives The switch for conversion from tacrolimus (TAC) twice daily-once daily recommended 1:1.The aim of this PK study was to evaluate TAC exposure in…”
    Get full text
    Journal Article
  6. 6

    Impact of A Multicomponent Intervention On Registered Nurses To Increase Reporting Of Adverse Drug Reactions And Medication Errors by Salcedo de Diego, I, Serrano Gallardo, P, Ruiz Antorán, B, de Andrés Gimeno, B, Revuelta Zamorano, M, Avendaño Solá, C

    Published in Clinical therapeutics (01-08-2015)
    “…A multicomponent intervention was designed based on the Patient Safety Institutional Policy and the results of a cross-sectional study carried out in June 2013…”
    Get full text
    Journal Article
  7. 7

    Randomized Clinical Trial, Placebo Compared To Evaluate The Efficacy And Safety of Minocycline In Angelman Syndrome (A-Manece Study) by Ruiz-Antorán, B, Sancho López, A, Cazorla, R, Iglesias, G, Lara, J, López Pájaro, L, Marín, E, Avendaño-Solá, C

    Published in Clinical therapeutics (01-08-2015)
    “…Angelman syndrome (AS) is a rare disease with serious developmental disorder. [...]no cure for AS exists. Recently published studies show an improvement of…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Knowledge about Biosimilars in Primary Care: a study by the Spanish Society of Primary Care Physicians (SEMERGEN) by Micó-Pérez, R M, Payares-Herrera, C, Palomo-Jiménez, P I, Sánchez-Fierro, J, Avendaño-Solá, C, Llisterri-Caro, J L

    Published in Semergen, medicina de familia (01-09-2018)
    “…The objective of this study was to evaluate the awareness and training needs on biosimilar drugs in Primary Care (PC) physicians. Descriptive cross-sectional…”
    Get full text
    Journal Article
  10. 10

    Results from the 2012-2013 paediatric national survey on off-label drug use in children in Spain (OL-PED study) by Piñeiro Pérez, R, Ruiz Antorán, M B, Avendaño Solá, C, Román Riechmann, E, Cabrera García, L, Cilleruelo Ortega, M J, Mellado Peña, M J

    “…Off-label drug use is a common practice in paediatrics. The aim of the present study was to estimate the knowledge of Spaniard paediatricians on off-label use…”
    Get full text
    Journal Article
  11. 11

    Conocimiento sobre biosimilares en Atención Primaria: Un estudio de la Sociedad Española de Médicos de Atención Primaria (SEMERGEN) by Micó-Pérez, R.M, Payares-Herrera, C, Palomo-Jiménez, P.I, Sánchez-Fierro, J, Avendaño-Solá, C, Llisterri-Caro, J.L

    Published in Semergen, medicina de familia (01-09-2018)
    “…Resumen Introducción El objetivo de este estudio fue evaluar el grado de conocimiento y las necesidades de formación sobre fármacos biosimilares en los médicos…”
    Get full text
    Journal Article
  12. 12

    Conocimiento sobre el uso de fármacos off-label en Pediatría. Resultados de una encuesta pediátrica nacional 2012-2013 (estudio OL-PED) by Piñeiro Pérez, R, Ruiz Antorán, M.B, Avendaño Solá, C, Román Riechmann, E, Cabrera García, L, Cilleruelo Ortega, M.J, Mellado Peña, M.J

    “…Resumen Introducción Un número elevado de fármacos se prescriben en niños bajo condiciones no autorizadas en ficha técnica (uso off-label). El objetivo…”
    Get full text
    Journal Article
  13. 13

    Patient involvement in clinical research: why, when, and how by Sacristán, José A, Aguarón, Alfonso, Avendaño-Solá, Cristina, Garrido, Pilar, Carrión, Juan, Gutiérrez, Alipio, Kroes, Robert, Flores, Angeles

    Published in Patient preference and adherence (2016)
    “…The development of a patient-centered approach to medicine is gradually allowing more patients to be involved in their own medical decisions. However, this…”
    Get full text
    Journal Article
  14. 14

    Clinical considerations on the posology of direct oral anticoagulants by Sáez-Peñataro, J., Avendaño-Solá, C., González-Juanatey, J.R.

    “…The efficacy of dicoumarin anticoagulants has been shown in patients with nonvalvular atrial fibrillation. However, they have drawbacks such as the need to…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Descriptive analysis of the electroencephalogram in Angelman syndrome by López-Pájaro, L F, Ruiz-Antorán, B, Marín-Serrano, E, Cazorla-Calleja, R, Iglesias-Escalera, G, Lara-Herguedas, J, García-Merino, J A, Avendaño-Solá, C, Sancho-López, A

    Published in Revista de neurologiá (16-01-2021)
    “…Angelman syndrome is a neurodevelopmental disorder of genetic origin, with important clinical motor, behavioural, communicative and electroencephalographic…”
    Get full text
    Journal Article
  17. 17
  18. 18

    The evaluation of the quality of clinical trials: the rationale, usefulness and drawbacks by García López, F J, Gutiérrez Bezón, S, Galende Domínguez, I, Avendaño Solá, C

    Published in Medicina clínica (1999)
    “…The quality of a randomised controlled trial should be understood as its internal validity, that is, the extent in which the study conclusions show correctly…”
    Get more information
    Journal Article
  19. 19